ESMO 2026 INTELLIGENCE · MADRIDKnow what top breast cancer KOLs think about your drug — before, during and after ESMO. Six seats only.Request the brochure →
GRG Health Talk to our team
← Back to insights
Case Studies · 19 September 2026 · 1 min read

Entering the Pneumococcal Vaccine Market in China: Landscape and Competitive Intelligence in 2.5 Weeks

A pharma company weighing entry into China's pneumococcal vaccine market needed the current and future landscape — and the competitive picture — before committing.

Using our hybrid CATI/online methodology backed by desk research, we delivered the full engagement in 2.5 weeks, from recruitment through follow-up questions. The speed came from in-market, in-language recruiters working relationships we already held — not from cutting corners on verification.

Market-entry decisions rarely wait. Neither do we. Facing a market you don't know yet? Talk to our team.

Want the full read?

The complete piece, including the respondent base and methodology, is available to clients on request.

Talk to our team